PTK2 and lung adenocarcinoma: In lung adenocarcinoma, the editing of specific intron sites on chr8:141,702,274 in the FAK transcript increases the stability of FAK mRNA and expression of the FAK protein, thereby promoting tumor mesenchymal properties, migration and invasion [34].